CODEX DNA INC. news, videos and press releases
For more news please use our advanced search feature.
CODEX DNA INC. - More news...
CODEX DNA INC. - More news...
- Telesis Bio Reports First Quarter 2024 Financial Results
- Telesis Bio Announces Reverse Stock Split
- Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
- Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
- Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
- Telesis Bio Reports Third Quarter 2023 Financial Results
- Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
- Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
- Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
- Telesis Bio Appoints William J. Kullback Chief Financial Officer
- Telesis Bio Reports Second Quarter 2023 Financial Results
- Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
- Telesis Bio to Present at Jefferies Healthcare Conference 2023
- Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
- Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
- Telesis Bio Secures Financing of $28.0 Million
- Telesis Bio to Present at SynBioBeta 2023
- Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
- Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
- Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
- Telesis Bio Reports First Quarter 2023 Financial Results
- Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
- Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
- Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
- Telesis Bio to Present at Festival of Biologics Conference
- Telesis Bio to Present at RNA Leaders Europe Congress
- Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023
- Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference
- Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation
- Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results